A Resource Guide to Investing in Biotechnology
Directory - Encyclopedia - Stock Index - Drugs  

Biotech100 Stock Index

Cell Genesys

About Cell Genesys:

Cell Geneys is focused on the development and commercialization of novel biological therapies for cancer.

They have six clinical stage programs derived from two product platforms: GVAX cancer vaccines and oncolytic virus therapies. Current treatment targets include cancers of the prostate, lung and pancreas, as well as hematologic cancers such as luekemia and myeloma.


Pipeline Chart for Cell Genesys (Clinical Stage)


Pipeline Chart for Cell Genesys (all products)


Phase I,II,IIGVAX (vaccine) Prostate, lung, pancreatic, leukemia, myeloma
Phase II,IICG7870 Oncolytic Virus TherapyProstate



More on Cell Genesys :

Home Page

Key Statistics for Cell Genesys

Basic Chart for Cell Genesys

Analyst Opinion

Analysts Estimates

Healine News

Biotech100 Index
What are the Requirements to be listed in the Biotech100 Index?
See the Biotech100 List

Sponsored Links

Clinical Trials
What is a Clinical Trial?
Phase I ,-- Phase II, -- PhaseIII
What is Randomized Control?
 What is a Double Blind Experiment?
What is the role of the FDA?


Key Biotech Terms


Biotech Resources


Investing in Stocks
Small Cap Stocks
Stocks and Bonds
Biotech100 Index

Careers and Employment
Biotechnology and Pharmaceutical
What are the Fastest Growing Careers?




Copyright 2005 BIOTECH100.COM. All rights reserved.